Ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease: 6-month follow-up data from the phase 2 REACH1 trial Meeting Abstract
| Authors: | Jagasia, M.; Ali, H.; Schroeder, M. A.; Shah, N. N.; Chen, Y. B.; Dawkins, F.; Arbushites, M.; Tian, C.; Perales, M. A. |
| Abstract Title: | Ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease: 6-month follow-up data from the phase 2 REACH1 trial |
| Meeting Title: | 45th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 54 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Mar 24-27 |
| Meeting Location: | Frankfurt, Germany |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2019-07-03 |
| Start Page: | 79 |
| End Page: | 80 |
| Language: | English |
| ACCESSION: | WOS:000487707800076 |
| PROVIDER: | wos |
| PUBMED: | 31270397 |
| DOI: | 10.1038/s41409-019-0562-9 |
| Notes: | Meeting Abstract: O079 -- Source: Wos |
